Lake Oswego, OR - A single-chamber implantable cardioverter-defibrillator (ICD) with the novel addition of atrial-sensing capability to its one lead has been granted market approval by the FDA, Biotronik announced today .
Its Lumax 740 DX system can potentially provide the benefits of atrial sensing to selected patients who might benefit, without the added implantation time and complication risk that come with a dedicated atrial-sensing lead.
The Lumax 740 DX system is already available in Europe and Japan, Biotronik says.
Heartwire from Medscape © 2013
Cite this: Atrial-sensing single-lead ICD gets FDA clearance - Medscape - Feb 25, 2013.